Transfection of NSCLC cells with HAS2, CD44, or RHAMM siRNA significantly reduced the expression of the respective genes (data not shown) and reduced the viability of NSCLC cells (Figure 3A), albeit with different efficiency. Here, HAS2 is linked to non-small cell lung carcinoma.